GENEVA, Feb 15 (Reuters) - The World Health Organization
(WHO) on Monday listed AstraZeneca and Oxford
University's COVID-19 vaccine for emergency use, widening access
to the relatively inexpensive shot in the developing world.
A WHO statement said it had approved the vaccine as produced
by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute
of India.
(Reporting by John Revill, John Miller, Michael Shields in
Zurich, Kate Kelland in London, Editing by William Maclean)